We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Top-Ranked Non-Tech S&P 500 Stocks for 2026 That Have Surged in 2025
Read MoreHide Full Article
Key Takeaways
S&P 500 has gained 16.7% in 2025, with several non-tech giants leading the charge.
GM, MS, IBKR, LVS and UHS each show rising earnings estimates and growth potential.
These diverse leaders span autos, finance, trading, leisure, and healthcare sectors.
U.S. stock markets have been witnessing an astonishing rally since the beginning of 2023 barring some minor fluctuations. Wall Street’s most observed benchmark — the S&P 500 Index — has advanced 16.7% year to date.
Although the rally has been primarily driven by the global boom in artificial intelligence (AI) technology, several non-tech behemoths have popped this year, aside from technology bigwigs. Investment in these stocks with a favorable Zacks Rank should be fruitful in 2026.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
General Motors Co.
General Motors remains the top-selling U.S. automaker with a 17% market share, driven by strong demand for its Chevrolet, GMC, Buick, and Cadillac brands. GM’s U.S. manufacturing expansion and China restructuring—where sales rose 10% year over year in the last reported quarter — support long-term growth.
GM’s software and services arm is becoming a key profit engine, with $2 billion in revenue year to date and 11 million OnStar subscribers. Strong liquidity of $35.7 billion and robust buybacks boosts investor confidence. Additionally, the Auto Tariff Offset Process should increase GM’s domestic cost competitiveness. Backed by strong brands, operational recovery in China, and software-led diversification, GM appears well-positioned for sustained earnings growth and shareholder value creation.
General Motors has an expected revenue and earnings growth rate of -0.7% and 7.9%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 10.8% over the last 30 days.
Morgan Stanley
Morgan Stanley’s focus on wealth and asset management operations along with its strategic alliances and acquisitions will aid the top line. The deal to buy EquityZen will help MS tap the rapidly growing private markets landscape. The performance of the investment banking (IB) business will continue to be driven by a strong pipeline. We project MS’ total revenues and IB fees to increase 11.7% and 12.8% in 2025, respectively.
On the other hand, while MS’ trading revenues have been increasing, growth in the same might become challenging in the future because of the volatile nature of the business. Yet, MS’ efficient capital distributions reflect a solid balance sheet.
Morgan Stanley has an expected revenue and earnings growth rate of 4.1% and 5.8%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 3.7% over the last 30 days.
Interactive Brokers Group Inc.
Interactive Brokers Group’s efforts to develop proprietary software, lower compensation expenses relative to net revenues, enhance its emerging market customers and global footprint, along with relatively high rates, are expected to continue aiding revenues.
IBKR’s third-quarter 2025 results reflected solid revenue growth and lower expenses. IBKR’s efforts to develop proprietary software and enhance its emerging market customers and global footprint, along with relatively high rates and lower compensation expenses relative to net revenues, are expected to support its top-line growth. IBKR’s initiatives to expand its product suite and the reach of its services will bolster its market share.
Interactive Brokers Group has an expected revenue and earnings growth rate of 5.3% and 7.8%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 1.4% in the last seven days.
Las Vegas Sands Corp.
Las Vegas Sands reported third-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. Both metrics increased on a year-over-year basis by 77.3% and 24.2%, respectively. LVS is benefiting from strong travel demand and improved operating conditions in Macao and Singapore.
LVS reported solid progress on its strategic goals and continued to focus on driving growth in both regions through the ongoing capital investments. In Singapore, strong performance at Marina Bay Sands was supported by new suite offerings and rising travel across Asia. LVS remains focused on expanding non-gaming opportunities in Macao.
Las Vegas Sands has an expected revenue and earnings growth rate of 5.1% and 7.3%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 10.1% over the last 30 days.
Universal Health Services Inc.
Universal Health Services continues to benefit from its expansion efforts in both the Acute Care and Behavioral Health segments, with increased licensed bed capacity driving patient volumes and revenue growth. UHS’ net revenues increased 9.9% year over year in the first nine months of 2025. UHS expects net revenues between $17.306 billion and $17.445 billion in 2025.
Acute Care unit's revenues rose 11.5% year over year in the first nine months of 2025. UHS remains committed to shareholder returns, repurchasing $565.8 million in shares in the first nine months of 2025 and maintaining consistent dividends. In October, management authorized a $1.5 billion increase to its share repurchase program.
Universal Health Services has an expected revenue and earnings growth rate of 5% and 7.7%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 0.1% over the last seven days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
5 Top-Ranked Non-Tech S&P 500 Stocks for 2026 That Have Surged in 2025
Key Takeaways
U.S. stock markets have been witnessing an astonishing rally since the beginning of 2023 barring some minor fluctuations. Wall Street’s most observed benchmark — the S&P 500 Index — has advanced 16.7% year to date.
Although the rally has been primarily driven by the global boom in artificial intelligence (AI) technology, several non-tech behemoths have popped this year, aside from technology bigwigs. Investment in these stocks with a favorable Zacks Rank should be fruitful in 2026.
Five such stocks are — General Motors Co. (GM - Free Report) , Morgan Stanley (MS - Free Report) , Interactive Brokers Group Inc. (IBKR - Free Report) , Las Vegas Sands Corp. (LVS - Free Report) and Universal Health Services Inc. (UHS - Free Report) . Each of our picks currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
General Motors Co.
General Motors remains the top-selling U.S. automaker with a 17% market share, driven by strong demand for its Chevrolet, GMC, Buick, and Cadillac brands. GM’s U.S. manufacturing expansion and China restructuring—where sales rose 10% year over year in the last reported quarter — support long-term growth.
GM’s software and services arm is becoming a key profit engine, with $2 billion in revenue year to date and 11 million OnStar subscribers. Strong liquidity of $35.7 billion and robust buybacks boosts investor confidence. Additionally, the Auto Tariff Offset Process should increase GM’s domestic cost competitiveness. Backed by strong brands, operational recovery in China, and software-led diversification, GM appears well-positioned for sustained earnings growth and shareholder value creation.
General Motors has an expected revenue and earnings growth rate of -0.7% and 7.9%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 10.8% over the last 30 days.
Morgan Stanley
Morgan Stanley’s focus on wealth and asset management operations along with its strategic alliances and acquisitions will aid the top line. The deal to buy EquityZen will help MS tap the rapidly growing private markets landscape. The performance of the investment banking (IB) business will continue to be driven by a strong pipeline. We project MS’ total revenues and IB fees to increase 11.7% and 12.8% in 2025, respectively.
On the other hand, while MS’ trading revenues have been increasing, growth in the same might become challenging in the future because of the volatile nature of the business. Yet, MS’ efficient capital distributions reflect a solid balance sheet.
Morgan Stanley has an expected revenue and earnings growth rate of 4.1% and 5.8%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 3.7% over the last 30 days.
Interactive Brokers Group Inc.
Interactive Brokers Group’s efforts to develop proprietary software, lower compensation expenses relative to net revenues, enhance its emerging market customers and global footprint, along with relatively high rates, are expected to continue aiding revenues.
IBKR’s third-quarter 2025 results reflected solid revenue growth and lower expenses. IBKR’s efforts to develop proprietary software and enhance its emerging market customers and global footprint, along with relatively high rates and lower compensation expenses relative to net revenues, are expected to support its top-line growth. IBKR’s initiatives to expand its product suite and the reach of its services will bolster its market share.
Interactive Brokers Group has an expected revenue and earnings growth rate of 5.3% and 7.8%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 1.4% in the last seven days.
Las Vegas Sands Corp.
Las Vegas Sands reported third-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. Both metrics increased on a year-over-year basis by 77.3% and 24.2%, respectively. LVS is benefiting from strong travel demand and improved operating conditions in Macao and Singapore.
LVS reported solid progress on its strategic goals and continued to focus on driving growth in both regions through the ongoing capital investments. In Singapore, strong performance at Marina Bay Sands was supported by new suite offerings and rising travel across Asia. LVS remains focused on expanding non-gaming opportunities in Macao.
Las Vegas Sands has an expected revenue and earnings growth rate of 5.1% and 7.3%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 10.1% over the last 30 days.
Universal Health Services Inc.
Universal Health Services continues to benefit from its expansion efforts in both the Acute Care and Behavioral Health segments, with increased licensed bed capacity driving patient volumes and revenue growth. UHS’ net revenues increased 9.9% year over year in the first nine months of 2025. UHS expects net revenues between $17.306 billion and $17.445 billion in 2025.
Acute Care unit's revenues rose 11.5% year over year in the first nine months of 2025. UHS remains committed to shareholder returns, repurchasing $565.8 million in shares in the first nine months of 2025 and maintaining consistent dividends. In October, management authorized a $1.5 billion increase to its share repurchase program.
Universal Health Services has an expected revenue and earnings growth rate of 5% and 7.7%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 0.1% over the last seven days.